abstract |
Disclosed are methods and compositions for treating IgE-related diseases usi ng NNT-1 inhibitors. In one embodiment, the present invention relates to a meth od of treating IgE-related diseases using a selective binding agent to NNT-1. I n another embodiment, the present invention relates to a method of treating Ig E- related diseases using an NNT-1 expression modulator. Methods of modulating IgE levels, and of diagnosing, preventing and/or treating certain types of allergic diseases using NNT-1 inhibitors are also disclosed. |